Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Takeda boots a top prospect out of its late-stage pipeline while another is delayed by war, lockdown
4 years ago
R&D
J&J taps a longtime vet to run its consumer health spinoff ahead of next year's separation
4 years ago
People
Pharma
AstraZeneca bows first ad campaign for lupus med Saphnelo, highlights patients' personal experiences
4 years ago
Pharma
Marketing
Cytiva's latest project to open in Switzerland at the end of the month
4 years ago
Pharma
Manufacturing
FDA user fee reauthorizations turn into rare bipartisan lovefest at House hearing
4 years ago
FDA+
Wisconsin giving Arrowhead Pharmaceuticals some cheddar as their new manufacturing site receives several million in ...
4 years ago
Pharma
Manufacturing
Moderna's new CFO out after former employer unveils internal auditing investigation
4 years ago
People
Pharma
Former Immunomedics CFO Usama Malik indicted for allegedly giving ex-girlfriend insider info
4 years ago
People
The collapse of SKYSCRAPER-01 is casting a pall over all the TIGITs. Are we in for another I/O fiasco?
4 years ago
Bioregnum
R&D
Covid-19 roundup: Cancer biotech to submit EUA for Covid drug; FDA OKs Eli Lilly JAK inhibitor
4 years ago
Coronavirus
Iterum says FDA is in 'general alignment' on proposed new PhIII for rejected uUTI drug
4 years ago
R&D
FDA hits Amicus with delay on 'breakthrough' Pompe drug
4 years ago
FDA+
AstraZeneca and Sanofi sharpen RSV pitch with new analyses, but how much weight will FDA give them?
4 years ago
R&D
With 30-year industry chops, Pamela Conley launches a protein therapeutics biotech for autoimmune diseases
4 years ago
Financing
Startups
Inovio's longtime CEO is out as Covid vaccine laggard throws in the towel on PhIII, pivots to booster
4 years ago
People
Roche goes 0-2 in the high-stakes race to get a TIGIT through PhIII and onto the market
4 years ago
R&D
Scoop: Green Valley's seaweed-derived Alzheimer's drug, approved in China, is halted in PhIII study
4 years ago
R&D
China
Bausch Health stock plummets even as company looks to start 'new chapter'
4 years ago
Pharma
Just months after its first FDA approval, Idorsia dumps binge-eating drug candidate after PhII fail
4 years ago
R&D
Sun Pharma site hit with second Form 483 in 3 years
4 years ago
Pharma
Manufacturing
Emergent tossed nearly 400M Covid-19 vaccine doses in Baltimore debacle, House report says
4 years ago
Pharma
Coronavirus
CSL, plasma companies win reversal on suit over Border Patrol blockade of visas for paid collections
4 years ago
Pharma
Law
UCB details positive pivotal data for myasthenia gravis, days after AstraZeneca scores OK for Soliris successor
4 years ago
Pharma
ICER: Merck's Covid-19 pill doesn't show 'net health benefit' but price is reasonable
4 years ago
Pharma
Coronavirus
First page
Previous page
533
534
535
536
537
538
539
Next page
Last page